Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for fourth quarter and full year ended December 31, 2018 before the open of U.S. financial markets on Wednesday, February 27, 2019.
| SAN JOSE, Calif., /PRNewswire/ -- Semler Scientific Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for fourth quarter and full year ended December 31, 2018 before the open of U.S. financial markets on Wednesday, February 27, 2019. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 11 a.m. ET the same day. The conference call may be accessed by dialing 877-359-9508 for domestic callers and 224-357-2393 for international callers. Please specify to the operator that you would like to join the “Semler Fourth Quarter and Year End 2018 Financial Results Call, conference ID#: 3068129.” The conference call will be archived on Semler’s website at www.semlerscientific.com. About Semler Scientific, Inc.: Semler Scientific, Inc. is an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific’s mission is to develop, manufacture and market innovative proprietary products and services that assist its customers in evaluating and treating chronic diseases. Semler Scientific’s first patented and U.S. Food and Drug Administration, or FDA, cleared product, introduced commercially in 2011, measured arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. In March 2015, Semler Scientific received FDA 510(k) clearance for the next generation version of this product named QuantaFlo™, which was commercially launched in August 2015 to more comprehensively evaluate our customers’ patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care. Additional information about Semler can be found at semlerscientific.com. CONTACT:
SOURCE Semler Scientific, Inc. | ||
Company Codes: OTC-BB:SMLR, OTC-PINK:SMLR, OTC-QB:SMLR |
View original content:
